Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says
This article was originally published in The Tan Sheet
Executive Summary
Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision
You may also be interested in...
Martek Fiscal 2002 Sales Jump 144.7%; WIC Acceptance Aids Growth
Infant formulas fortified with Martek Biosciences' DHA and ARA fatty acids have been accepted by the WIC program in roughly 15 states, Chief Executive Officer Henry Linsert said in a Dec. 12 analysts call
Similac Advance
Ross Products' infant formula fortified with Martek Biosciences' DHA, ARA fatty acid oils will be available by mid-April in food, drug, mass stores, Abbott Labs division says. Advance will come in 12.9 oz. and 25.7 oz. powder, 32 oz. ready-to-feed plastic bottle; formula will be priced at 15% premium over existing products. Ross says it has received FDA clearance for its GRAS petition, submitted Jan. 2; firm will be second to market fortified formula in the U.S. following Mead Johnson's launch of Enfamil LIPIL, reaching shelves this month (1"The Tan Sheet" Jan. 14, 2002, p. 3)...
DHA/ARA Term Infant Formula Negative Findings Cast Doubt On Launches
Negative research results relating to DHA/ARA supplementation of term infant formulas could delay the U.S. launch of formulas containing the fatty acids.